These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 6372026)

  • 1. Role of anaerobic bacteria in bite-wound infections.
    Goldstein EJ; Citron DM; Finegold SM
    Rev Infect Dis; 1984; 6 Suppl 1():S177-83. PubMed ID: 6372026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiology of human and animal bite wounds in children.
    Brook I
    Pediatr Infect Dis J; 1987 Jan; 6(1):29-32. PubMed ID: 3822614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group.
    Talan DA; Citron DM; Abrahamian FM; Moran GJ; Goldstein EJ
    N Engl J Med; 1999 Jan; 340(2):85-92. PubMed ID: 9887159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiology and management of human and animal bite wound infections.
    Brook I
    Prim Care; 2003 Mar; 30(1):25-39, v. PubMed ID: 12825249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaerobic infections in childhood.
    Brook I
    Rev Infect Dis; 1984; 6 Suppl 1():S187-92. PubMed ID: 6372028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriology of human and animal bite wounds.
    Goldstein EJ; Citron DM; Wield B; Blachman U; Sutter VL; Miller TA; Finegold SM
    J Clin Microbiol; 1978 Dec; 8(6):667-72. PubMed ID: 744798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    J Antimicrob Chemother; 1998 Mar; 41(3):391-6. PubMed ID: 9578167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
    J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerobic and anaerobic microbiologic factors and recovery of beta-lactamase producing bacteria from obstetric and gynecologic infection.
    Brook I; Frazier EH; Thomas RL
    Surg Gynecol Obstet; 1991 Feb; 172(2):138-44. PubMed ID: 1989117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of human and animal mouth flora.
    Rayan GM; Downard D; Cahill S; Flournoy DJ
    J Okla State Med Assoc; 1991 Oct; 84(10):510-5. PubMed ID: 1744782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy.
    Goldstein EJ; Citron DM; Vagvolgyi AE; Finegold SM
    Antimicrob Agents Chemother; 1986 Apr; 29(4):556-9. PubMed ID: 3707104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bite wound infections].
    Yaqub S; Bjørnholt JV; Hellum KB; Steinbakk M; Enger AE
    Tidsskr Nor Laegeforen; 2004 Dec; 124(24):3194-6. PubMed ID: 15608763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
    Goldstein EJ; Citron DM
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1143-8. PubMed ID: 3190202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and animal bite infections.
    Brook I
    J Fam Pract; 1989 Jun; 28(6):713-8. PubMed ID: 2656906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bacteriology and antimicrobial susceptibility of infected and non-infected dog bite wounds: fifty cases.
    Meyers B; Schoeman JP; Goddard A; Picard J
    Vet Microbiol; 2008 Mar; 127(3-4):360-8. PubMed ID: 18029118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bite wounds and infection.
    Goldstein EJ
    Clin Infect Dis; 1992 Mar; 14(3):633-8. PubMed ID: 1562653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments.
    Talan DA; Abrahamian FM; Moran GJ; Citron DM; Tan JO; Goldstein EJ;
    Clin Infect Dis; 2003 Dec; 37(11):1481-9. PubMed ID: 14614671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.